Skip to main content
Medic Debate
- The Antidote to Medical Misinformation and Propaganda!
Languages
Dansk
Nederlands
English
Français
Deutsch
Italiano
Español
Kiswahili
Svenska
Search form
Search
Main menu
Home
Search
About us
Books
Category Search
Log In
Recent posts
Treatment Protocols
You are here
Home
Dasatinib
Items per page
5
10
20
40
60
100
Title
Average Rating
Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer.
80.00%
Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis.
60.00%
Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells.
50.00%